It is thus conceivable that either HJURP or DAXX carries out a chaperone like function for CENPA in prostate cancer, although re-ChIP assays involving CENPA and HJURP together or CENPA and DAXX together would be necessary to prove the presence of such a mechanism. Here, HJURP is linked to prostate cancer.